I’m not alone in pointing this out, but if there’s one thing about research and clinical trials into “complementary and alternative medicine” (CAM) that has become very apparent to me over the years, it’s that the more rigorous the study the less likely it is to show an effect. In normal research, the usual progression […]
Category: Clinical trials
A key pillar of the Stanislaw Burzynski antineoplaston marketing machine, a component of the marketing strategy without which his clinic would not be able to attract nearly as many desperate cancer patients to Houston for either his antineoplaston therapy (now under a temporary shutdown by the FDA that, if science were to reign, will become […]
Share this:
I’ve been very, very critical of a self-proclaimed cancer doctor named Stanislaw Burzynski, who is not an oncologist but somehow has managed over the last 36 years to treat patients with unapproved cancer drugs, list dozens of phase 2 clinical trials in ClinicalTrials.gov but never publish a completed one (at least to this date), and […]
Share this:
Stem cells are magical, mystical things that can’t be explained. At least, if you listen to what docs and “practitioners” who run stem cell clinics in various parts of the world, usually where regulation is lax and money from First World clientele is much sought after, that’s what you could easily come to believe. Unfortunately, […]
Share this:
In the United States, the federal government has long had a prominent role in funding science research. Be it the $30 billion a year or so that funds the National Institutes of Health or the $5 or $6 billion a year allotted to the National Science Foundation, the government funds a lot of basic and […]
